Debt-to-equity of Repare Therapeutics Inc. from 31 Mar 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Repare Therapeutics Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2021 to 30 Sep 2025.
  • Repare Therapeutics Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 15%, a 8.4% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Repare Therapeutics Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 15% -1% -8.4% 30 Sep 2025
Q2 2025 17% -1% -4.6% 30 Jun 2025
Q1 2025 16% -3% -17% 31 Mar 2025
Q4 2024 16% -9% -37% 31 Dec 2024
Q3 2024 17% -11% -40% 30 Sep 2024
Q2 2024 18% -13% -41% 30 Jun 2024
Q1 2024 20% -14% -41% 31 Mar 2024
Q4 2023 25% -8% -23% 31 Dec 2023
Q3 2023 28% -4% -14% 30 Sep 2023
Q2 2023 30% -2% -5.4% 30 Jun 2023
Q1 2023 33% +3% +8.5% 31 Mar 2023
Q4 2022 33% +3% +9.2% 31 Dec 2022
Q3 2022 32% +3% +10% 30 Sep 2022
Q2 2022 32% +6% +23% 30 Jun 2022
Q1 2022 31% +7% +29% 31 Mar 2022
Q4 2021 30% 31 Dec 2021
Q3 2021 29% 30 Sep 2021
Q2 2021 26% 30 Jun 2021
Q1 2021 24% 31 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.